Artivion Inc(AORT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 5:05 PM ET (Korea 9/12 06:05)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.07 | Insider Own | 5.35% | Shs Outstand | 48.7M | Perf Week | -2.11% |
| Market Cap | 1.22B | Forward P/E | 86.86 | EPS next Y | 206.94% | Insider Trans | -4.55% | Shs Float | 46.1M | Perf Month | -12.43% |
| Enterprise Value | 1.55B | PEG | 2.88 | EPS next Q | -0.06 | Inst Own | 94.48% | Short Float | 6.34% | Perf Quarter | 21.75% |
| Income | -0.00B | P/S | 2.59 | EPS this Y | -228.57% | Inst Trans | 4.22% | Short Ratio | 4.06 | Perf Half Y | -30.66% |
| Sales | 0.47B | P/B | 2.74 | EPS next 5Y | 30.11% | ROA | -0.33% | Short Interest | 2.93M | Perf YTD | -45.01% |
| Book/sh | 9.15 | P/C | 15.81 | EPS past 3/5Y | - | ROE | -0.73% | 52W High | -48.02% ($48.25) | Perf Year | -40.72% |
| Cash/sh | 1.59 | P/FCF | - | Sales past 3/5Y | 12.04% 11.75% | ROIC | -0.37% | 52W Low | 30.9% ($19.16) | Perf 3Y | 59.44% |
| Dividend Est. | - | EV/EBITDA | 27.84 | EPS Y/Y TTM | 85.99% | Gross Margin | 61.17% | Volatility(W/M) | 3.8% 3.99% | Perf 5Y | 1.01% |
| Dividend TTM | - | EV/Sales | 3.29 | Sales Y/Y TTM | 16.4% | Oper. Margin | 6.63% | ATR (14) | 1.08 | Perf 10Y | 45.48% |
| Dividend Ex-Date | 2015/12/9 | Quick Ratio | 2.01 | EPS Q/Q | -1039.19% | Profit Margin | -0.67% | RSI (14) | 40.44 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.97 | Sales Q/Q | 11.32% | SMA20 | -6.56% ($26.84) | Beta | 1.22 | Target Price | $42.15 |
| Payout | - | Debt/Eq | 0.92 | Earnings | 2026/8/6 | SMA50 | -4.34% ($26.22) | Rel Volume | 0.75 | Prev Close | $24.65 |
| Employees | 1800 | LT Debt/Eq | 0.9 | EPS/Sales Surpr. | -11300% 4.8% | SMA200 | -24.76% ($33.33) | Avg Volume(3M) | 0.72M | Price | $25.08 |
| IPO | 1993/2/12 | Option/Short | Yes/Yes | Trades | 7001 | Volume | 539,823 | Change | 1.74% |
Company
AORT is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Artivion is a cardiac and vascular surgery medical device company focused on treating aortic diseases. The company supplies aortic stent grafts, On-X mechanical heart valves, surgical sealants, vascular grafts, and cardiac and vascular tissue preservation services to the global market. It is a specialty medical device company that provides surgeons with a broad range of aortic treatment solutions through its direct sales organization and distribution network spanning North America, Europe, Asia, and Latin America.
Over the past 1 year, on the lower side
48% below its 1-year high.
AORT has weak earning power
6.63% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -228.6% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +59.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 94.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SAWS 0.03%
TFGZ 0.02%
XHE 0.02%
HTEC 0.02%
NANC 0.01%It ranks #4 in the industry
Based on market cap of $1B.
AORT $1B PER -
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is AORT?
AORT belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of AORT?
The market cap of AORT is approximately $1.2B, ranking 2,484 within its sector.
What is the 52-week high and low for AORT?
AORT has recorded a 52-week high of $48.25 and a low of $19.16.
